SCHEMBL31715978

SCHEMBL31715978

COc1cc2nc(Cc3ccc(-c4cccc(F)c4)nc3)[nH]c(=O)c2cc1OC

nearest known ligand 0.48

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
▸ LMNA P02545 4/20 0.48
▸ KDM4E B2RXH2 5/20 0.46
▸ TDP1 Q9NUW8 1/20 0.46
▸ GAA P10253 1/20 0.45
▸ PDGFRB P09619 1/20 0.45
▸ PDGFRA P16234 1/20 0.45
▸ MAPK1 P28482 2/20 0.45
▸ ALDH1A1 P00352 2/20 0.45
▸ USP2 O75604 1/20 0.45
▸ ALOX15 P16050 1/20 0.45
▸ CASP1 P29466 1/20 0.44
▸ HBB P68871 1/20 0.44
▸ MET P08581 2/20 0.43
▸ THRB P10828 1/20 0.42
▸ HPGD P15428 1/20 0.42
▸ AHR P35869 1/20 0.42
▸ ROCK2 O75116 1/20 0.42
▸ PDE10A Q9Y233 2/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31715994 0.86 KDM4E (0.46) LMNAKDM4ETDP1GAAMAPK1
Hydrochloric Acid SCHEMBL31716568 0.85 LMNA (0.45) LMNAKDM4ETDP1GAAMAPK1
SCHEMBL31716946 0.85 LMNA (0.44) LMNAKDM4ETDP1GAAMAPK1
SCHEMBL31716955 0.84 LMNA (0.43) LMNAKDM4ETDP1GAAMAPK1
SCHEMBL31716050 0.84 LMNA (0.43) LMNAKDM4ETDP1GAAMAPK1
SCHEMBL31717042 0.84 LMNA (0.43) LMNAKDM4ETDP1GAAMAPK1
SCHEMBL31716882 0.83 MAPK1 (0.46) LMNAKDM4ETDP1GAAMAPK1
SCHEMBL31715980 0.82 LMNA (0.42) LMNAKDM4ETDP1GAAMAPK1
SCHEMBL31716099 0.81 LMNA (0.41) LMNAKDM4ETDP1GAAMAPK1
Hydrochloric Acid SCHEMBL31716036 0.81 LMNA (0.41) LMNAROCK2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2025227032-A1 METHODS FOR DEGRADATION OF CYCLIN K AND INHIBITION OF CYCLIN DEPENDENT KINASES REMIX THERAPEUTICS INC. (US) 2025-10-30 — — WO disclosed
Send feedback